Aspirin, being an anti-platelet, anti-inflammatory, and analgesic agent, is well-accepted as a secondary preventive agent of cardiovascular events. However, it is linked with certain limitations. Aspirin resistance is a significant hurdle, especially in noncompliant patients.

This commentary talks about  the etiology of aspirin resistance, and how it can be assessed for modifying the aspirin therapy if required.